Earlier this week, the U.S. Food and Drug Administration approved the Optune device, which treats patients with glioblastoma multiforme (GBM).Treatment with this device is in addition to standard treatments such as surgery, radiation therapy and chemotherapy. “White the treatment is not a cure, it can increase survival time by months” said William Maisel, M.D., M.P.H., acting director of the Office of Device Evaluation in the FDA’s Center for Devices and Radiological Health. Read more here >> http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm465744.htm
Posted in: Other
